Kyverna Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $75.2M
Liabilities Breakdown FY2023
Total Liabilities: $26.0M
Asset Breakdown
Total Assets: $75.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $34.6M | 46.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.3M | 3.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $38.2M | 50.8% |
Liabilities Breakdown
Total Liabilities: $26.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.4M | 16.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $21.7M | 83.3% |